Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice
Emilie Giaime, Youren Tong, Lisa Katharina Wagner, et al.
Neuron (2017) Vol. 96, Iss. 4, pp. 796-807.e6
Open Access | Times Cited: 115

Showing 26-50 of 115 citing articles:

Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms
Asad Malik, Athanasios Karapetsas, Raja Sekhar Nirujogi, et al.
Biochemical Journal (2021) Vol. 478, Iss. 3, pp. 553-578
Open Access | Times Cited: 41
Presynaptic endocytic factors in autophagy and neurodegeneration
Domenico Azarnia Tehran, Marijn Kuijpers, Volker Haucke
Current Opinion in Neurobiology (2018) Vol. 48, pp. 153-159
Closed Access | Times Cited: 58
Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
Farah H. Bardai, Dalila G. Ordonez, Rachel M. Bailey, et al.
PLoS Biology (2018) Vol. 16, Iss. 12, pp. e2006265-e2006265
Open Access | Times Cited: 53
Autophagy and LRRK2 in the Aging Brain
Federica Albanese, Salvatore Novello, Michele Morari
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 50
Progress in LRRK2-Associated Parkinson’s Disease Animal Models
Steven P. Seegobin, George R. Heaton, Dongxiao Liang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 40
The Cell Biology of LRRK2 in Parkinson's Disease
Ahsan Usmani, Farbod Shavarebi, Annie Hiniker
Molecular and Cellular Biology (2021) Vol. 41, Iss. 5
Open Access | Times Cited: 34
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Eunice Eun Seo Chang, Philip Wing‐Lok Ho, Huifang Liu, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 23
The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition
Kaela Kelly, Shijie Wang, Ravindra Boddu, et al.
Experimental Neurology (2018) Vol. 309, pp. 1-13
Open Access | Times Cited: 44
Inhibition of LRRK2 restores parkin-mediated mitophagy and attenuates intervertebral disc degeneration
Jialiang Lin, Xuan-Qi Zheng, Zengjie Zhang, et al.
Osteoarthritis and Cartilage (2021) Vol. 29, Iss. 4, pp. 579-591
Open Access | Times Cited: 31
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity
Abby L. Olsen, Mel Β. Feany
Neurobiology of Disease (2021) Vol. 159, pp. 105482-105482
Open Access | Times Cited: 30
Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in a C. elegans Model of LRRK2-Induced Parkinson’s Disease
Devin Naidoo, Alexandre de Lencastre
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8795-8795
Open Access | Times Cited: 4
Protection of Green Tea Polyphenols against Neurodegenerative Diseases: Evidence and Possible Mechanisms
Yan Zhao, Baolu Zhao
Journal of Nutrition (2025)
Closed Access
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2
Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Environmental Factors Exacerbate Parkinsonian Phenotypes in an Asian-Specific Knock-In LRRK2 Risk Variant in Mice
Zoë Bichler, Sarivin Vanan, Zhiwei Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3556-3556
Open Access
Roles of LRRK2 and its orthologs in protecting against neurodegeneration and neurodevelopmental defects
An Phu Tran Nguyen, Linh Thi Nhat Nguyen, Bodil Stokke, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders
Sudhanshu P. Raikwar, Nidhi S. Kikkeri, Ragha Sakuru, et al.
Journal of Neuroimmune Pharmacology (2019) Vol. 14, Iss. 4, pp. 608-641
Open Access | Times Cited: 32
Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression
Hümeyra Nur Kaleli, Ebru Ozer, Veysel Oğulcan Kaya, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 553-553
Open Access | Times Cited: 31
Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease
Juozas Gordevičius, Peipei Li, Lee Marshall, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Biomolecules (2023) Vol. 13, Iss. 1, pp. 178-178
Open Access | Times Cited: 10
LRRK2 regulates synaptic function through BDNF signaling and actin cytoskeleton
Giulia Tombesi, Shiva N. Kompella, Giulia Favetta, et al.
(2024)
Open Access | Times Cited: 3
Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease
Ping‐Yue Pan, Yingbo Zhu, Yuan Shen, et al.
Neurobiology of Disease (2018) Vol. 122, pp. 64-71
Open Access | Times Cited: 30
LRRK2 mediates axon development by regulating Frizzled3 phosphorylation and growth cone–growth cone communication
Keisuke Onishi, Runyi Tian, Bo Feng, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 30, pp. 18037-18048
Open Access | Times Cited: 27
α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome
Rui Wang, Hongyang Sun, Haigang Ren, et al.
Science China Life Sciences (2020) Vol. 63, Iss. 12, pp. 1850-1859
Closed Access | Times Cited: 27
Physiological and pathological roles of LRRK2 in the nuclear envelope integrity
Vered Shani, Hazem Safory, Raymonde Szargel, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 23, pp. 3982-3996
Open Access | Times Cited: 26
Long-term exposure to 2-amino-3-methylimidazo[4,5-f]quinoline can trigger a potential risk of Parkinson's disease
Zhi Li, Peipei Cao, Huiling Meng, et al.
Journal of Hazardous Materials (2021) Vol. 412, pp. 125230-125230
Closed Access | Times Cited: 21

Scroll to top